Invuity Secures $36M in Series E Financing

The round, which is a combination of $21m in equity and up to $15m in debt, was led by HealthCare Royalty Partners, along with existing investors Valence Life Sciences, InterWest Partners, Kleiner Perkins Caufield and Byers, and a number of other investors.

The company intends to use the funds to accelerate commercial initiatives across its product line of devices for minimally invasive surgery.